Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected )
Also on site :
- Trump economic advisor confident in China trade deal conclusion on Monday
- Trump advisor expects China trade deal conclusion Monday
- Игра и не только: вклад Haier в будущее молодежи и устойчивое развитие